What is the pathophysiology of sarcoidosis?

Pathophysiology of Sarcoidosis

Sarcoidosis is fundamentally an immune-mediated granulomatous disease triggered by an unknown antigen in genetically susceptible individuals, characterized by dysregulated T-cell responses and macrophage activation that lead to the formation of non-caseating granulomas in affected organs.

Core Immunological Mechanisms

The pathophysiology centers on aberrant crosstalk between innate and adaptive immunity 1. The disease process unfolds through several interconnected mechanisms:

Antigen Trigger and Genetic Susceptibility

While the exact etiology remains uncertain, the disease likely results from exposure to unidentified environmental antigens (possibly mycobacterial or propionibacterial organisms) in individuals with genetic predisposition 2. Some evidence suggests pathogenic microbial antigens and tissue antigens may trigger a hyperimmune Th1 response, potentially involving aberrant aggregation of serum amyloid A within granulomas 2.

T-Cell Mediated Response

The disease exhibits a strong T helper-1 (Th1) and Th17 signature with excessive IFN-γ production 1. Key features include:

• Oligoclonal expansion of CD4+ T cells consistent with chronic antigenic stimulation 2
• Involvement of Th1, Th17, and Th17.1 cells driving the inflammatory cascade 1
• Elevated CD4+/CD8+ ratio in bronchoalveolar lavage fluid (BALF), a characteristic immunological finding 3
• Impaired regulatory T-cell function that fails to counterbalance the excessive activation 1, 2
• Progressive T-cell exhaustion over time 1

Macrophage Activation and Granuloma Formation

Granulomas form through macrophage differentiation at the core, fueled by aberrantly programmed monocytes 1. The histological hallmark is:

• Compact, tightly formed collections of large "epithelioid" histiocytes and multinucleated giant cells arranged in concentrically organized layers 4
• Central core of macrophage aggregates surrounded by an outer layer of loosely organized lymphocytes (mostly T cells) with interposed dendritic cells 4
• Perilymphatic distribution: granulomas characteristically locate around bronchovascular bundles, interlobular septa containing pulmonary veins, and near visceral pleura 4
• Sparse surrounding lymphocytic infiltrate, distinguishing it from other granulomatous diseases 4

Perpetuating Inflammatory Loop

The disease creates a self-sustaining cycle: hyperactive macrophages drive excessive peripheral cell recruitment while persistent antigen presentation to T cells maintains the response 1. Dysregulated Toll-like receptor signaling further amplifies inflammation 2. Deficient regulatory pathways fail to terminate this activation, creating progressive chronic granulomatous inflammation 1.

Vascular Involvement

An often-overlooked component is granulomatous angiitis with invasion of vascular walls 4. The microangiopathy of sarcoidosis involves:

• Endothelial injury and multilamellation of basement membranes in microvessels 5
• Frequent vascular involvement in lungs, heart, eyes, and skin 5

Progression to Fibrosis

While many granulomas may spontaneously resolve or respond to treatment, some undergo fibrotic transformation 5. The fibrotic process:

• Begins at the granuloma periphery with extension centrally, with or without calcification 4
• Particularly affects granulomas along bronchovascular bundles and interlobular septa 5
• In chronic fibrotic stage, upper lung lobes become scarred and contracted with fibrous bands between hilar regions and pleura 5
• Can lead to cystic changes, honeycombing, and progressive pulmonary impairment 5

Organ-Specific Pathophysiology

Cardiac Involvement

Cardiac sarcoidosis involves granulomatous myocardial inflammation disrupting both cardiac structure and electrical conduction 6. The process includes:

• CD4+ T-cell and macrophage activity with cytokine signaling leading to myocardial fibrosis 6
• Can manifest as conduction abnormalities, ventricular arrhythmias, heart failure, or sudden cardiac death 6

Clinical Implications

The pathophysiology explains the clinical heterogeneity: disease presentation depends on which organs are affected, the extent of granulomatous inflammation, and whether the process resolves or progresses to fibrosis 7. The immunological snapshot changes over time as cellular composition in both circulation and tissue microenvironment evolves 7.

Critical caveat: The diagnosis requires non-necrotizing granulomas as the hallmark feature 4. However, variants (particularly nodular pulmonary sarcoidosis) can present with mixed necrotic and non-necrotic granulomas 4. Extensive necrosis, "dirty" necrosis with nuclear debris, or palisading granulomas argue against sarcoidosis 4.